Risk of Erectile Dysfunction and Retrograde Ejaculation Associated with Thulium Laser Vaporesection of the Prostate for Bladder Outflow Obstruction: A Retrospective Study
Authors:
- Raj P. PalRPRaj P. Pal
- Andrew BatchelderABAndrew Batchelder
- Masood A. KhanMKMasood A. Khan
- 10 January 2012
- journal article
- Published by S. Karger AG in Urologia Internationalis
- Vol. 88 (2) , 165-169
Abstract
Objective: The aim of this study was to determine the incidence of erectile dysfunction and retrograde ejaculation following thulium:yttrium-aluminium-garnet (Tm:YAG) laser prostate vaporesection (ThuVaRP). Patients and Methods: Between January 2009 and June 2010, 113 consecutive patients underwent ThuVaRP for bladder outflow obstruction. Of these, 54 (48%) were included in the study as they were able to maintain an erection for sexual intercourse prior to undergoing ThuVaRP. All patients had benign pathology and had not undergone previous bladder neck surgery. The incidence of erectile dysfunction and retrograde ejaculation was reported at a mean follow-up period of 12 months post-operatively. Results: The mean patient age was 71 years (range 46–90). The mean follow-up period was 12 months (range 4–21). 11 (20%) patients experienced worsening erectile function with 3 (6%) noticing an improvement. A total of 30 patients (56%) experienced some degree of retrograde ejaculation. 4 patients (7%) noticed an improvement in their ejaculation. Retrograde ejaculation was more common in patients with an indwelling catheter in situ for refractory urinary retention (43 vs. 17%, p = 0.04) and in diabetic patients (27 vs. 4%, p = 0.03). There was an increased trend of erectile dysfunction in men aged ≧70 years, with hypertension and with hypercholesterolaemia, but this was not significant. Conclusion: Our retrospective study has demonstrated that the overall risk of erectile dysfunction and retrograde ejaculation associated with ThuVaRP is 20 and 56%, respectively.Keywords
This publication has 24 references indexed in Scilit:
- Thulium:YAG 2 μm cw laser prostatectomy: where do we stand?World Journal of Urology, 2010
- Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstructionWorld Journal of Urology, 2010
- Vaporesection for managing benign prostatic hyperplasia using a 2‐µm continuous‐wave laser: a prospective trial with 1‐year follow‐upBJU International, 2009
- Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trialsBMJ, 2008
- Thulium Laser versus Standard Transurethral Resection of the Prostate: A Randomized Prospective TrialEuropean Urology, 2008
- RevoLix™ vaporesection of the prostate: initial results of 54 patients with a 1-year follow-upWorld Journal of Urology, 2007
- The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic HyperplasiaNew England Journal of Medicine, 2003
- Photoselective Vaporization of the Prostate: Initial Experience with a New 80 W KTP Laser for the Treatment of Benign Prostatic HyperplasiaJournal of Endourology, 2003
- Introduction and Concluding RemarksEuropean Urology, 1999
- Holmium laser prostatectomyCurrent Opinion in Urology, 1998